XP builds Brazil's largest eye-care network ahead of IPO

XP’s private-equity arm has created Vision One, now Brazil’s largest eye-care network, by merging its CBV holding with Grupo H.Olhos. The newly formed entity generates roughly R$500 million (US$98 million) in annual revenue and operates about 65 clinics and hospitals spread across 30 cities and 13 states. The combination immediately captures slightly more than 5% of a highly fragmented domestic market.

The acquisition firepower originates from the FIP XP Private Equity fund, which closed roughly R$1.3 billion (US$255 million) in February. The vehicle is led by Chu Kong, a seasoned executive who founded TMG Capital in the 1990s and later spent more than a decade at Actis. His team initially deployed about R$200 million (US$39 million) to secure control of CBV, establishing it as the foundation for a broader consolidation effort.

Brazil hosts more than 5,000 independent eye clinics and hospitals, a classic fragmented landscape where no single operator has ever achieved dominance. Eye care offers specific appeal for this type of roll-up because procedures like cataract removal and vision correction can be easily standardized across locations. Furthermore, the sector provides the defensive, cash-generative profiles that private equity typically favors.

The demographic underpinning for the bet is Brazil's significant underpenetration compared to developed markets. The country currently performs only about three eye surgeries per 1,000 people each year, a fraction of the ten procedures per 1,000 people recorded in the United States. As Brazil’s population ages, XP is betting that demand for these treatments will structurally increase.

Vision One represents a broader shift in Brazilian finance, where capital is aggressively chasing healthcare sub-sectors where scale can lift both clinical quality and profit margins. The endgame for XP's fund is a public listing within two to three years. This anticipated IPO will serve as a crucial benchmark for whether Latin American healthcare roll-ups can sustain public market valuations.

The central challenge for Kong’s team will be operational execution. Aggregating independent clinics under a single corporate umbrella is a common private-equity tactic, but integrating them into a cohesive, consistently profitable network is where many healthcare consolidations fail. Market participants will monitor whether Vision One can maintain margin discipline as it continues to acquire sites ahead of its scheduled exit.